LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients

Abroad (travel likely)Recruiting

Conditions

End-stage Heart Failure

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • CHU Besançon, Besançon, France

    Contact: Study coordinator (MARIE FRANCE SERONDE, Pr)
    Contact: Principal Investigator (MARIE FRANCE SERONDE, Pr)
  • Hôpital Pneumologique et Cardiovasculaire Louis Pradel, Bron, France

    Contact: Study coordinator (MATTEO POZZI, Dr) · matteo.pozzi@chu-lyon.fr · 4 72 35 71 49
  • CHU Caen, Caen, France

    Contact: Study coordinator (KATRIEN DR BLANCHART, Dr)
    Contact: Principal Investigator (KATRIEN DR BLANCHART, Dr)
  • La Tronche Hospital / CHU Grenoble, La Tronche, France

    Contact: Study coordinator (AUDE BOIGNARD) · aboignard@chu-grenoble.fr
    Contact: Principal Investigator (AUDE BOIGNARD, Dr)
  • Arnaud de Villeneuve Hospital / CHU Montpellier, Montpellier, France

    Contact: Study coordinator (Valentin DUPASQUIER) · valentin.dupasquier@chu-montpellier.fr
    Contact: Principal Investigator (PASCAL BAPTISTELLA, Dr)
  • CHU Rouen, Rouen, France

    Contact: Study coordinator (FABRICE BAUER)
    Contact: Principal Investigator (FABRICE BAUER)
  • CHU Tours, Tours, France

    Contact: Study coordinator (Thierry BOURGUIGNON, Dr)
    Contact: Principal Investigator (Thierry BOURGUIGNON)
  • CHRU, Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu, Vandœuvre-lès-Nancy, France

    Contact: Study coordinator (GUILLAUME BAUDRY) · g.baudry@chru-nancy.fr · 3 83 15 73 31
    Contact: Principal Investigator (GUILLAUME BAUDRY, Dr)
Study leads
  • Guillaume BAUDRY, Dr

    Principal Investigator

    CHRU Nancy